JAMA Network
About The Study: A proposed U.S. Drug Enforcement Administration rule could impede buprenorphine initiation for a substantial number of patients with opioid use disorder. In this study, more than 4,500 tele-buprenorphine initiations from 2020 to 2022—20% of tele-initiations overall—would have been prohibited under requirements for an in-person visit with the tele-initiating clinician prior to or within 30 days after tele-initiation.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
